DCP-001 becomes vididencel

What we doOur approachPipelineTechnologyPublications
About usExecutive ManagementBoard of DirectorsScientific Advisory Board
News & eventsPress releasesEventsInterviews
Investors
Careers

Back
DCP-001 becomes vididencel
Stockholm, Sweden
 1:00:00 AM

Keep reading
Immunicum AB (publ) Publishes Prospectus in Connection with Rights Issue and Directed IssueRead